JFL Life Sciences Limited (NSE:JFLLIFE)
India · Delayed Price · Currency is INR 10.30
-0.30 (-2.83%)
At close: Jan 21, 2026
JFL Life Sciences Market Cap
JFL Life Sciences has a market cap or net worth of 331.6 million as of January 23, 2026. Its market cap has decreased by -50.57% in one year.
Market Cap
331.60M
Enterprise Value
421.72M
Revenue
744.78M
Ranking
n/a
PE Ratio
12.55
Stock Price
10.30
Market Cap Chart
Since September 8, 2022, JFL Life Sciences's market cap has decreased from 731.40M to 331.60M, a decrease of -54.66%. That is a compound annual growth rate of -20.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 331.60M | -19.60% |
| Dec 31, 2025 | 412.44M | -59.35% |
| Dec 30, 2024 | 1.01B | 122.29% |
| Dec 29, 2023 | 456.44M | 22.06% |
| Dec 30, 2022 | 373.95M | -48.87% |
| Sep 8, 2022 | 731.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Panjon | 452.29M |
| Walpar Nutritions | 449.33M |
| Welcure Drugs and Pharmaceuticals | 432.58M |
| Murae Organisor | 427.56M |
| Vilin Bio Med | 403.16M |
| Gujarat Terce Laboratories | 341.96M |
| Deccan Health Care | 325.15M |
| ANG Lifesciences India | 324.11M |